League City: 
Houston Veterinarian Dr. Steven D. Garner Invited to Present on
Regenerative and Stem Cell Therapies at Major 2026 Veterinary Conferences:
ACVIM Forum and ABVP Symposium
Houston, Texas – February 16, 2026 – Dr. Steven D. Garner of Safari Veterinary Care Center in Houston has been invited to deliver expert presentations on regenerative medicine at two leading veterinary conferences in 2026: the American College of Veterinary Internal Medicine (ACVIM) Forum and the American Board of Veterinary Practitioners (ABVP) Symposium.
At the ABVP Symposium 2026 (April 9–12, 2026, at the Westin Boston Seaport District in Boston, Massachusetts), Dr. Garner will present “Regenerative Therapy” on Saturday, April 11. The ABVP Symposium offers focused, high-quality continuing education with innovative sessions and practical insights for species-specific veterinary care.
He will also present in the ABVP track at the ACVIM Forum 2026 (June 11–13, 2026, in Seattle, Washington) on “Stem Cell Therapy in Veterinary Medicine: Practical Applications for General and Specialty Practice.” The ACVIM Forum is a flagship event for veterinary internal medicine specialists worldwide.
These prestigious invitations highlight Dr. Garner’s more than 10 years of clinical experience and research in regenerative medicine, with a focus on mesenchymal stem cell (MSC) therapy—particularly allogeneic adipose-derived MSCs—for musculoskeletal, neurological, immunological, and degenerative conditions in companion animals. His work emphasizes tissue repair, immune modulation, reduced dependence on long-term immunosuppression, and seamless integration into general and specialty practices.
A cornerstone of his contributions is a 2025 retrospective study published in Stem Cells and Development (PMID: 40908140), “Intravenous Allogeneic Mesenchymal Stem Cell Therapy for Canine Immune-Mediated Hemolytic Anemia: A Retrospective Clinical Evaluation.” The study reviewed 157 client-owned dogs treated with intravenous allogeneic MSC therapy as an adjunct to standard immunosuppression for primary immune-mediated hemolytic anemia (IMHA), often in refractory cases. In a core cohort of 43 dogs (strict criteria: confirmed primary IMHA, no major comorbidities, at least two MSC treatments), 76% achieved sustained hematological recovery (packed cell volume ≥30%). Improvements were seen across the broader group, with no serious adverse events post-infusion, demonstrating excellent safety and tolerability.
“Being selected for these platforms is a tremendous honor and an exciting chance to share evidence-based regenerative approaches that can transform pet care,” said Dr. Garner. “From practical stem cell applications to adjunctive therapies for challenging conditions like IMHA, we’re advancing options that improve outcomes, enhance quality of life, and move beyond chronic medications.”
For more information about Dr. Garner’s presentations, regenerative medicine services (including stem cell therapy), or Safari Veterinary Care Center, please contact:
Dr. Steven D. Garner Safari Veterinary Care Center 281-332-5612 sgarner@safarivet.com www.safarivet.com
About ACVIM The American College of Veterinary Internal Medicine advances veterinary internal medicine through education, research, and specialty care.
About ABVP The American Board of Veterinary Practitioners promotes excellence in species-specialized veterinary practice through board certification and continuing education.
Media Contact:
Melinda Wharton
Marketing Coordinator
Safari Veterinary Care Centers
281-332-5612
mwharton@safarivet.com
www.safarivet.com
https://www.facebook.com/SafariVeterinaryCareCenters
